Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China
· Delayed Price · Currency is CNY 11.24
-0.02 (-0.18%)
Apr 29, 2026, 3:04 PM CST
Yifan Pharmaceutical Revenue
Yifan Pharmaceutical had revenue of 1.26B CNY in the quarter ending March 31, 2026, a decrease of -5.36%. This brings the company's revenue in the last twelve months to 5.06B, down -1.91% year-over-year. In the year 2025, Yifan Pharmaceutical had annual revenue of 5.13B, down -0.52%.
Revenue (ttm)
5.06B
Revenue Growth
-1.91%
P/S Ratio
2.31
Revenue / Employee
1.21M
Employees
4,098
Market Cap
11.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.13B | -26.87M | -0.52% |
| Dec 31, 2024 | 5.16B | 1.09B | 26.84% |
| Dec 31, 2023 | 4.07B | 231.47M | 6.03% |
| Jan 1, 2023 | 3.84B | -572.39M | -12.98% |
| Jan 1, 2022 | 4.41B | -991.34M | -18.36% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.04B |
| CSPC Hunan Jingfeng Pharmaceutical | 393.19M |
| Aurora Optoelectronics | 465.12M |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Shanghai InnoStar Bio-tech | 811.33M |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Nanjing Pharmaceutical Group Company | 54.96B |
| Chongqing Lummy Pharmaceutical | 759.50M |